Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06688942 · ClinicalTrials.gov registry record · NA
Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease
A NA study of Quality of Life and Chronic Graft Versus Host Disease, sponsored by University of Miami.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06688942: Active NA study of Quality of Life and Chronic Graft Versus Host Disease, sponsored by University of Miami.
NCT06688942 is a NA study of Quality of Life and Chronic Graft Versus Host Disease that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 20 participants, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06688942, a NA study of Quality of Life and Chronic Graft Versus Host Disease, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to learn if the Horizons mobile application is feasible for survivors of allogeneic hematopoietic stem cell transplant who have chronic graft-versus-host disease. Participants will be asked to complete surveys and use the Horizons mobile application.
Primary Outcome
Participant enrollment will be demonstrated if ≥60% eligible participants enroll.
Conditions Studied
Interventions
- BEHAVIORAL Horizons App Intervention
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-04 |
| Est. Completion | 2026-03-25 |
| Phase | NA |
What the registry record for NCT06688942 still lists
NCT06688942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Horizons App Intervention is the first listed.
NCT06688942 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06688942 about?
NCT06688942 is a clinical study titled "Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease". The goal of this interventional study is to learn if the Horizons mobile application is feasible for survivors of allogeneic hematopoietic stem cell transplant who have chronic graft-versus-host disease. Participants will be asked to complete surveys and use the Horizons mobile application.
What is the current status of trial NCT06688942?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-12-04. Estimated completion is 2026-03-25.
What conditions does trial NCT06688942 study?
This clinical trial studies the following conditions: Quality of Life, Chronic Graft Versus Host Disease.
What interventions are being tested in trial NCT06688942?
The interventions under investigation include: Horizons App Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06688942?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06688942 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06688942's enrollment target sits among peer trials
20 98th of 107 higher than 8 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI